Liminatus Pharma selects Synex to advance CAR-T trial
Executive Overview In a significant milestone for the field of hematological oncology and cellular immunotherapy, Liminatus Pharma has officially engaged...
Executive Overview In a significant milestone for the field of hematological oncology and cellular immunotherapy, Liminatus Pharma has officially engaged...